Treatment of advanced head and neck cancer: Multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach

✍ Scribed by Nissenbaum, Michael ;Browde, Selma ;Bezwoda, Werner R. ;de Moor, Norah G. ;Derman, Dennis P.

• Publisher: John Wiley and Sons
• Year: 1984
• Tongue: English
• Weight: 435 KB
• Volume: 12
• Category: Article
• ISSN: 0098-1532
• DOI: 10.1002/mpo.2950120312

✦ Synopsis

Fifty-eight patients with advanced head and neck cancer were entered into a randomised trial comparing chemotherapy (DDP + bleomycin) alone, multiple daily fractionated radiation therapy, and multimodality therapy consisting of chemotherapy plus multiple fractionated radiation therapy. Multimodal therapy gave a significantly higher response rate (69%) than either single-treatment modality. The use of a multiple daily dose fractionation allowed radiation therapy to be completed over 10 treatment days, and the addition of chemotherapy to the radiation treatment did not significantly increase toxicity. Patients receiving multimodal therapy also survived significantly longer (median 50 weeks) than those receiving single-modality therapy (median 24 weeks).